The Impact of COVID-19 on Gastrointestinal Motility Testing in Asia and Europe.
COVID-19
SARS-CoV-2
anorectal manometry
breath tests
catheter-based pH-monitoring
infection prevention
motility disorders of the gastrointestinal tract
oesophageal manometry
wireless pH-monitoring (Bravo®)
Journal
Journal of clinical medicine
ISSN: 2077-0383
Titre abrégé: J Clin Med
Pays: Switzerland
ID NLM: 101606588
Informations de publication
Date de publication:
01 Oct 2020
01 Oct 2020
Historique:
received:
21
08
2020
revised:
19
09
2020
accepted:
29
09
2020
entrez:
6
10
2020
pubmed:
7
10
2020
medline:
7
10
2020
Statut:
epublish
Résumé
The new coronavirus disease (COVID-19) has high infection and mortality rates, and has become a pandemic. The infection and mortality rates are lower in Asian countries than in European countries. This study aimed to conduct a survey on the effects of COVID-19 on the capacity to perform gastrointestinal motility tests in Asian countries compared with European countries. We used the questionnaire previously established by our team for researchers in European countries. The correlation between the decreased rate of gastrointestinal motility and function tests, and the infection/mortality rates of COVID-19 and stringency of a government's interventions in each country was analysed and protective measures were assessed. In total, 58 gastroenterologists/motility experts in Asian countries responded to this survey. The infection/mortality rates of COVID-19 and Stringency Index had a significant impact on the testing capacity of oesophageal manometry and catheter-based pH monitoring. In European countries, most facilities used filtering facepiece 2/3 (FFP2/3) masks during oesophageal motility studies. Meanwhile, in Asian countries, most facilities used surgical masks. The total infection and mortality rates of COVID-19 can affect the rate of gastrointestinal motility testing and the type of protective equipment that must be used.
Sections du résumé
BACKGROUND
BACKGROUND
The new coronavirus disease (COVID-19) has high infection and mortality rates, and has become a pandemic. The infection and mortality rates are lower in Asian countries than in European countries. This study aimed to conduct a survey on the effects of COVID-19 on the capacity to perform gastrointestinal motility tests in Asian countries compared with European countries.
METHODS
METHODS
We used the questionnaire previously established by our team for researchers in European countries. The correlation between the decreased rate of gastrointestinal motility and function tests, and the infection/mortality rates of COVID-19 and stringency of a government's interventions in each country was analysed and protective measures were assessed.
RESULTS
RESULTS
In total, 58 gastroenterologists/motility experts in Asian countries responded to this survey. The infection/mortality rates of COVID-19 and Stringency Index had a significant impact on the testing capacity of oesophageal manometry and catheter-based pH monitoring. In European countries, most facilities used filtering facepiece 2/3 (FFP2/3) masks during oesophageal motility studies. Meanwhile, in Asian countries, most facilities used surgical masks.
CONCLUSION
CONCLUSIONS
The total infection and mortality rates of COVID-19 can affect the rate of gastrointestinal motility testing and the type of protective equipment that must be used.
Identifiants
pubmed: 33019626
pii: jcm9103189
doi: 10.3390/jcm9103189
pmc: PMC7600249
pii:
doi:
Types de publication
Journal Article
Langues
eng
Subventions
Organisme : Japan Society for the Promotion of Science (JSPS KAKENHI)
ID : 20H3667
Références
Euro Surveill. 2020 Apr;25(13):
pubmed: 32265003
J Neurogastroenterol Motil. 2018 Oct 1;24(4):577-583
pubmed: 30347936
Gene. 2020 Oct 20;758:144944
pubmed: 32628976
Int J Antimicrob Agents. 2020 Mar;55(3):105924
pubmed: 32081636
J Neurogastroenterol Motil. 2020 Jun 30;26(3):299-310
pubmed: 32606253
Ir J Med Sci. 2020 Nov;189(4):1143-1144
pubmed: 32212099
Gastroenterology. 2013 Apr;144(4):718-25; quiz e13-4
pubmed: 23277105
Gut. 2019 Nov;68(11):1928-1941
pubmed: 31375601
Neurogastroenterol Motil. 2020 Jul;32(7):e13930
pubmed: 32525249
Neurogastroenterol Motil. 2020 Jul;32(7):e13926
pubmed: 32478910
Neurogastroenterol Motil. 2012 Mar;24 Suppl 1:5-10
pubmed: 22248102
Dis Esophagus. 2020 Jan 16;33(1):
pubmed: 31313807
Health Policy. 2020 Sep;124(9):909-918
pubmed: 32631613
Digestion. 2017;95(1):72-78
pubmed: 28052285
Ann Coloproctol. 2019 Aug;35(4):160-166
pubmed: 31487762
Am J Gastroenterol. 2019 Aug;114(8):1265-1274
pubmed: 31295161
Emerg Infect Dis. 2020 May;26(5):1049-1052
pubmed: 32053479
J Pediatr Gastroenterol Nutr. 2010 Jun;50(6):601-8
pubmed: 20400913